Neuroreceptor mechanisms of aggression and its treatment.

Aggression results from the interaction of multiple systems. It can be classified as predatory, impulsive, or based on a medical condition. The likelihood of aggression is increased by environmental overstimulation or stress, transmitter balances favoring dopamine and excitatory amino acid transmission over serotonin and gamma-aminobutyric acid transmission, and the presence of problems related to impulsivity. Treatments for aggression are based on the underlying causes and generally should combine pharmacologic and environmental or psychotherapeutic measures. Useful pharmacologic agents include mood stabilizers and atypical antipsychotics that combine dopaminergic and serotonergic actions. Drugs acting on nicotine receptors may deserve further attention. Nonpharmacologic measures include behavioral techniques aimed at reducing impulsivity, relapse prevention techniques for substance abuse, and anger management techniques.

[1]  D. Dougherty,et al.  Antisocial personality disorder and alcohol-induced aggression. , 1998, Alcoholism, clinical and experimental research.

[2]  E. Barratt,et al.  Defining, measuring, and predicting impulsive aggression: a heuristic model. , 1998, Behavioral sciences & the law.

[3]  E. Daneluzzo,et al.  PANSS factors and scores in schizophrenic and bipolar disorders during an index acute episode: a further analysis of the cognitive component , 2002, Schizophrenia Research.

[4]  R. Hen,et al.  Insights into the Neurobiology of Impulsive Behavior from Serotonin Receptor Knockout Mice , 1997, Annals of the New York Academy of Sciences.

[5]  D. Cherek.  Effects of smoking different doses of nicotine on human aggressive behavior , 2004, Psychopharmacology.

[6]  P. Bräunig,et al.  Intravenous valproic acid in the treatment of severe catatonia. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[7]  J. Smiley.  Monoamines and acetylcholine in primate cerebral cortex: what anatomy tells us about function. , 1996, Revista brasileira de biologia.

[8]  C. Yesalis,et al.  Psychological and Behavioural Effects of Endogenous Testosterone and Anabolic-Androgenic Steroids , 1996, Sports medicine.

[9]  L. Wulsin,et al.  Group therapy in manic-depressive illness. , 1988, American journal of psychotherapy.

[10]  M. Linnoila,et al.  Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. , 1989, Archives of general psychiatry.

[11]  D. Dougherty,et al.  Measurement of inter-episode impulsivity in bipolar disorder , 2001, Psychiatry Research.

[12]  M. Amadeo.  Antiandrogen Treatment of Aggressivity in Men Suffering from Dementia , 1996, Journal of geriatric psychiatry and neurology.

[13]  E. Barratt,et al.  Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression. , 2002, Drug and alcohol dependence.

[14]  D. Januel,et al.  Lamotrigine--clozapine combination in refractory schizophrenia: three cases. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[15]  J. Bizot,et al.  Serotonin and tolerance to delay of reward in rats , 1999, Psychopharmacology.

[16]  A. Harris,et al.  Critical review of GABA-ergic drugs in the treatment of schizophrenia. , 1999, Journal of clinical psychopharmacology.

[17]  J. Grabowski,et al.  Human aggressive responding during acute tobacco abstinence: effects of nicotine and placebo gum , 1991, Psychopharmacology.

[18]  K. Phillips,et al.  Are impulse-control disorders related to bipolar disorder? , 1996, Comprehensive psychiatry.

[19]  J. Overall,et al.  Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation. , 1989, The American journal of psychiatry.

[20]  R. Ulrich,et al.  Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital , 2002, Schizophrenia Research.

[21]  K. Blennow,et al.  CSF studies in violent offenders¶I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy , 2001, Journal of Neural Transmission.

[22]  E. Levin,et al.  Nicotine–Haloperidol Interactions and Cognitive Performance in Schizophrenics , 1996, Neuropsychopharmacology.

[23]  I. Schweitzer,et al.  Aggressive Behaviour in Schizophrenia: The Role of Psychopathology , 1997, The Australian and New Zealand journal of psychiatry.

[24]  A. Depaulis,et al.  Gabaergic modulation of mouse-killing in the rat , 2004, Psychopharmacology.

[25]  D. Dougherty,et al.  Studies of violent and nonviolent male parolees: II. Laboratory and psychometric measurements of impulsivity , 1997, Biological Psychiatry.

[26]  E. Barratt,et al.  The impact of impulsivity on cocaine use and retention in treatment. , 2001, Journal of substance abuse treatment.

[27]  J. Evenden,et al.  The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement , 1996, Psychopharmacology.

[28]  J. Hennen,et al.  Estrogen therapy and aggressive behavior in elderly patients with moderate-to-severe dementia: results from a short-term, randomized, double-blind trial. , 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[29]  I. Mefford,et al.  CSF dopamine levels correlate with extraversion in depressed patients , 1986, Psychiatry Research.

[30]  C. Pomerleau,et al.  Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders , 1998, Schizophrenia Research.

[31]  M. Linnoila,et al.  CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. , 1990, The Journal of clinical psychiatry.

[32]  M. Zuckerman,et al.  P-impulsive sensation seeking and its behavioral, psychophysiological and biochemical correlates. , 1993, Neuropsychobiology.

[33]  D. Charney,et al.  Somnambulistic-like Episodes Secondary to Combined Lithium-Neuroleptic Treatment , 1979, British Journal of Psychiatry.

[34]  P. Södersten,et al.  Altered dopamine function in pathological gambling , 1997, Psychological Medicine.

[35]  O. Puciłowski,et al.  Enhanced affective aggression in genetically bred hypercholinergic rats. , 1990, Neuropsychobiology.

[36]  D. Stoff,et al.  Subtyping aggression in children and adolescents. , 1990, The Journal of neuropsychiatry and clinical neurosciences.

[37]  B. Sanders,et al.  Interaction of GABA and Excitatory Amino Acids in the Basolateral Amygdala: Role in Cardiovascular Regulation , 1997, The Journal of Neuroscience.

[38]  J. Nurnberger,et al.  Blunted ACTH and cortisol response to afternoon tryptophan infusion in euthymic bipolar patients , 1990, Psychiatry Research.

[39]  L. Siever,et al.  A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. , 2001, The Journal of clinical psychiatry.

[40]  I. Modai,et al.  Pindolol augmentation in aggressive schizophrenic patients: a double-blind crossover randomized study , 2001, International clinical psychopharmacology.

[41]  J. Lindenmayer,et al.  Use of sodium valproate in violent and aggressive behaviors: a critical review. , 2000, The Journal of clinical psychiatry.

[42]  M. Linnoila,et al.  Pathological gambling. A psychobiological study. , 1988, Archives of general psychiatry.

[43]  P. Mandel,et al.  Involvement of the GABAergic System on Shock-induced Aggressive Behavior in Two Strains of Mice , 1981, Pharmacology Biochemistry and Behavior.

[44]  S. Schulz,et al.  Violence and schizophrenia: clozapine as a specific antiaggressive agent. , 1995, The Bulletin of the American Academy of Psychiatry and the Law.

[45]  R. Kahn,et al.  Monoamines and Abnormal Behaviour a Multi-Aminergic Perspective , 1990, British Journal of Psychiatry.

[46]  R. Hector.  The use of clozapine in the treatment of aggressive schizophrenia. , 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[47]  John Evenden,et al.  The Behavior of Spontaneously Hypertensive and Wistar Kyoto Rats Under a Paced Fixed Consecutive Number Schedule of Reinforcement , 1999, Pharmacology Biochemistry and Behavior.

[48]  M. Bourin,et al.  Role of N-methyl-d-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[49]  R. Perry,et al.  Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. , 1984, Archives of general psychiatry.

[50]  E. Kouri,et al.  Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. , 1995, Drug and alcohol dependence.

[51]  J. Bjork,et al.  Endogenous plasma testosterone levels and commission errors in women: A preliminary report , 2001, Physiology & Behavior.

[52]  Karen Barlow,et al.  Prevalence and Precipitants of Aggression in Psychiatric Inpatient Units , 2000, The Australian and New Zealand journal of psychiatry.

[53]  D. Dougherty,et al.  Antisocial personality disorder and aggression in recently abstinent cocaine dependent subjects. , 1997, Drug and alcohol dependence.

[54]  M. Linehan,et al.  Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. , 1994, The American journal of psychiatry.

[55]  T. Robbins.  Arousal systems and attentional processes , 1997, Biological Psychology.

[56]  D R Cherek,et al.  Methylphenidate effects on a laboratory aggression measure in children with ADHD. , 1995, Psychopharmacology bulletin.

[57]  J. Leon,et al.  Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders , 2002, Schizophrenia Research.

[58]  Y. Lecrubier,et al.  CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects , 1999, Biological Psychiatry.

[59]  K. R. Britton,et al.  Medroxyprogesterone in the treatment of aggressive hypersexual behavior in traumatic brain injury. , 1998, Brain injury.

[60]  R. Belmaker,et al.  Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study. , 1979, Archives of general psychiatry.

[61]  M. McGue,et al.  Association between the adrenergic alpha 2A receptor gene (ADRA2A) and measures of irritability, hostility, impulsivity and memory in normal subjects. , 2000, Psychiatric genetics.

[62]  E. Susser,et al.  Divalproex treatment of disruptive adolescents: a report of 10 cases. , 1997, The Journal of clinical psychiatry.

[63]  G. Winterer,et al.  Valproate and the symptomatic treatment of schizophrenia spectrum patients. , 2000, Pharmacopsychiatry.

[64]  G. Gerra,et al.  Neurotransmitters, Neuroendocrine Correlates of Sensation-Seeking Temperament in Normal Humans , 1999, Neuropsychobiology.

[65]  T. Robbins,et al.  Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: New evidence for central dopaminergic-noradrenergic interactions , 2004, Psychopharmacology.

[66]  J. Brar,et al.  Impact of Risperidone on Seclusion and Restraint at a State Psychiatric Hospital , 2000, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[67]  C. Marvel,et al.  Topiramate Improves Deficit Symptoms in a Patient with Schizophrenia when Added to a Stable Regimen of Antipsychotic Medication , 2001, Clinical neuropharmacology.

[68]  A. Ab.  The pharmacology of impulsive behaviour in rats III: the effects of amphetamine, haloperidol, imipramine, chlordiazepoxide and ethanol on a paced fixed consecutive number schedule , 1998 .

[69]  R. Verkes,et al.  Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder , 1998, Biological Psychiatry.

[70]  J. Bjork,et al.  Laboratory measures of aggression and impulsivity in women with borderline personality disorder , 1999, Psychiatry Research.

[71]  J. Bjork,et al.  Differential Behavioral Effects of Plasma Tryptophan Depletion and Loading in Aggressive and Nonaggressive Men , 2000, Neuropsychopharmacology.

[72]  Thomas Haspel.  Beta‐blockers and the Treatment of Aggression , 1995, Harvard review of psychiatry.

[73]  A. Wassef,et al.  Divalproex Sodium Augmentation of Haloperidol in Hospitalized Patients With Schizophrenia: Clinical and Economic Implications , 2001, Journal of clinical psychopharmacology.

[74]  P. Grof,et al.  Varieties of lithium benefit , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[75]  G. Simpson,et al.  Does akathisia influence psychopathology in psychotic patients treated with clozapine? , 1999, Biological Psychiatry.

[76]  P. E. Chatham-Showalter.  Carbamazepine for combativeness in acute traumatic brain injury. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[77]  J. Mendels,et al.  Expressive characteristics of anxiety in depressed men and women. , 1993, Journal of affective disorders.

[78]  G. Dunn,et al.  Acting on Delusions. II: The Phenomenological Correlates of Acting on Delusions , 1993, British Journal of Psychiatry.

[79]  E. Barratt.  Psychophysiological correlates of classical differential eyelid conditioning among subjects selected on the basis of impulsiveness and anxiety. , 1971, Biological psychiatry.

[80]  E. Coccaro.  Central Serotonin and Impulsive Aggression , 1989, British Journal of Psychiatry.

[81]  E. Brown,et al.  Efficacy of divalproex therapy for schizoaffective disorder. , 2000, Journal of clinical psychopharmacology.

[82]  E. Susser,et al.  Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. , 2000, The American journal of psychiatry.

[83]  A. Zeichner,et al.  Effects of nicotine deprivation and irritability on physical aggression in male smokers. , 2001, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[84]  A. Damasio,et al.  Deciding Advantageously Before Knowing the Advantageous Strategy , 1997, Science.

[85]  D. Dougherty,et al.  Immediate versus delayed visual memory task performance among schizophrenic patients and normal control subjects , 1998, Psychiatry Research.

[86]  F. Aizpuru,et al.  Tobacco smoking and bipolar disorder. , 1998, The Journal of clinical psychiatry.

[87]  P. Driscoll,et al.  Selective inhibition by nicotine of shock-induced fighting in the rat , 1981, Pharmacology Biochemistry and Behavior.

[88]  M. Alpert,et al.  Adjunctive nadolol in the treatment of acutely aggressive schizophrenic patients. , 1996, The Journal of clinical psychiatry.

[89]  S. Leucht,et al.  Carbamazepine for schizophrenia and schizoaffective psychoses. , 2002, The Cochrane database of systematic reviews.

[90]  E. Coccaro,et al.  Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. , 1998, The Journal of clinical psychiatry.

[91]  M. Sheard,et al.  The effect of lithium on impulsive aggressive behavior in man. , 1976, The American journal of psychiatry.

[92]  R. Poland,et al.  CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors , 1996, Biological Psychiatry.

[93]  H. Silver.  Fluvoxamine as an adjunctive agent in schizophrenia. , 2006, CNS drug reviews.

[94]  P. Mandel,et al.  Effects of the potentiation of the GABAergic neurotransmission in the olfactory bulbs on mouse-killing behavior , 1986, Pharmacology Biochemistry and Behavior.

[95]  P Vaglum,et al.  The importance of ward atmosphere in inpatient treatment of schizophrenia on short-term units. , 1996, Psychiatric services.

[96]  R. Waldbillig.  Suppressive effects of intraperitoneal and intraventricular injections of nicotine on muricide and shock-induced attack on conspecifics , 1980, Pharmacology Biochemistry and Behavior.

[97]  J. Sirviö,et al.  Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task , 1998, Neuroscience.

[98]  C. Muntaner,et al.  Impulsiveness and subjective effects of intravenous cocaine administration in the laboratory. , 1994, Journal of substance abuse.

[99]  R. Plutchik,et al.  Panic-associated suicidal and aggressive ideation and behavior. , 1997, Journal of psychiatric research.

[100]  A. Harris,et al.  Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. , 2000, Journal of clinical psychopharmacology.

[101]  A. Arnsten,et al.  Catecholamine regulation of the prefrontal cortex , 1997, Journal of psychopharmacology.

[102]  F. Frankenburg,et al.  Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. , 2002, The Journal of clinical psychiatry.

[103]  W. Lancee,et al.  The relationship between nurses' limit-setting styles and anger in psychiatric inpatients. , 1995, Psychiatric services.

[104]  D. Sanger,et al.  Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies , 2000, Psychopharmacology.

[105]  G. Gerra,et al.  Neurotransmitter-neuroendocrine responses to experimentally induced aggression in humans: influence of personality variable , 1997, Psychiatry Research.

[106]  M. Sheard.  Effect of Lithium on Human Aggression , 1971, Nature.

[107]  S. File,et al.  Nicotinic–serotonergic interactions in brain and behaviour , 2002, Pharmacology Biochemistry and Behavior.

[108]  J. Dabbs,et al.  Salivary testosterone and cortisol in a delinquent and violent urban subculture. , 1996, The Journal of social psychology.

[109]  Barry J. Everitt,et al.  Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms , 1997, Psychopharmacology.

[110]  C. Ashby,et al.  Immediate effect of intravenous diazepam in neuroleptic-induced acute akathisia: an open-label study. , 2002, The Journal of clinical psychiatry.

[111]  E. Barratt,et al.  Psychiatric aspects of impulsivity. , 2001, The American journal of psychiatry.

[112]  J M Schmitz,et al.  Naltrexone and relapse prevention treatment for cocaine-dependent patients. , 2001, Addictive behaviors.

[113]  C. Normann,et al.  Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients. , 1999, Journal of clinical psychopharmacology.

[114]  M Linnoila,et al.  Extraversion in pathological gamblers. Correlates with indexes of noradrenergic function. , 1989, Archives of general psychiatry.

[115]  M. Åsberg,et al.  CSF 5-HIAA predicts suicide risk after attempted suicide. , 1994, Suicide & life-threatening behavior.

[116]  J. Gault,et al.  Smoking and mental illness , 2001, Pharmacology Biochemistry and Behavior.

[117]  S. Mobini,et al.  Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: a quantitative analysis , 2000, Psychopharmacology.

[118]  B. Bussel,et al.  Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial. , 1999, Brain injury.

[119]  P. Mandel,et al.  Effects of sodium n-dipropylacetate, muscimol hydrobromide and (R,S) nipecotic acid amide on isolation-induced aggressive behavior in mice , 2004, Psychopharmacology.

[120]  N. Beck,et al.  Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility. , 1997, The journal of the American Academy of Psychiatry and the Law.

[121]  C. Leung,et al.  SUICIDE ATTEMPT DUE TO METOCLOPRAMIDE‐INDUCED AKATHISIA , 1997, International journal of clinical practice.

[122]  F. Gerard Moeller,et al.  Studies of violent and nonviolent male parolees: I. Laboratory and psychometric measurements of aggression , 1997, Biological Psychiatry.

[123]  G. Berntson,et al.  Effects of nicotinic and muscarinic compounds on biting attack in the cat , 1976, Pharmacology Biochemistry and Behavior.

[124]  J. Overall,et al.  Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[125]  S. Glatt,et al.  Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[126]  M. Åsberg,et al.  Neuropsychological correlates of platelet monoamine oxidase (MAO) activity in female and male subjects , 1987, Biological Psychology.

[127]  E. Kouri,et al.  Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. , 2000, Archives of general psychiatry.

[128]  Neurotransmitter systems and personality measurements: a study in psychosomatic patients and healthy subjects. , 1988, Neuropsychobiology.

[129]  B. Brismar,et al.  Hormone levels and personality traits in abusive and suicidal male alcoholics. , 1994, Alcoholism, clinical and experimental research.

[130]  Masatoshi Tanaka,et al.  Local muscimol disinhibits mesolimbic dopaminergic activity as examined by brain microdialysis and Fos immunohistochemistry , 1997, Brain Research.

[131]  E. Barratt,et al.  Factor Analysis of Some Psychometric Measures of Impulsiveness and Anxiety , 1965, Psychological reports.

[132]  S. Ueki,et al.  Biochemical correlates in mouse-killing behavior of the rat: Prolonged isolation and brain cholinergic function , 1977, Pharmacology Biochemistry and Behavior.

[133]  M S Buchsbaum,et al.  Effects of amphetamine on vigilance performance in normal and hyperactive children , 1980, Journal of abnormal child psychology.

[134]  S. Kupietz,et al.  Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[135]  J. Tiihonen,et al.  Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia , 1995, Acta psychiatrica Scandinavica.

[136]  F. Benes.  The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. , 1997, Journal of psychiatric research.

[137]  J. Evenden.  The pharmacology of impulsive behaviour in rats II: the effects of amphetamine, haloperidol, imipramine, chlordiazepoxide and other drugs on fixed consecutive number schedules (FCN 8 and FCN 32) , 1998, Psychopharmacology.

[138]  P. Brain,et al.  Clozapine: Strong antiaggressive effects with minimal motor impairment , 1992, Physiology & Behavior.

[139]  Marie-Odile Krebs,et al.  Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity , 2001, Psychiatry Research.

[140]  G. Currier,et al.  The Expert Consensus Guideline Series. Treatment of behavioral emergencies. , 2001, Postgraduate medicine.

[141]  Frederick K. Goodwin,et al.  Aggression in humans correlates with cerebrospinal fluid amine metabolites , 1979, Psychiatry Research.

[142]  T. Kent,et al.  The effects of phenytoin on impulsive and premeditated aggression: a controlled study. , 1997, Journal of clinical psychopharmacology.

[143]  M. Oquendo,et al.  The biology of impulsivity and suicidality. , 2000, The Psychiatric clinics of North America.

[144]  C. Gacono,et al.  Treatment of antisocial personality, psychopathy, and other characterologic antisocial syndromes. , 2000, Behavioral sciences & the law.

[145]  W. M. Davis,et al.  Psychopharmacologic violence associated with cocaine abuse: Kindling of a limbic dyscontrol syndrome? , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[146]  E. Robins,et al.  Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. , 1987, Archives of general psychiatry.